These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28366429)

  • 1. The Growing "Stem Cell Clinic" Problem.
    Kuriyan AE; Albini TA; Flynn HW
    Am J Ophthalmol; 2017 May; 177():xix-xx. PubMed ID: 28366429
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell clinics: risk of proliferation.
    Sissung TM; Figg WD
    Lancet Oncol; 2020 Feb; 21(2):205-206. PubMed ID: 32007195
    [No Abstract]   [Full Text] [Related]  

  • 3. Unproven but Profitable: The Boom in US Stem Cell Clinics.
    Rubin R
    JAMA; 2018 Oct; 320(14):1421-1423. PubMed ID: 30326510
    [No Abstract]   [Full Text] [Related]  

  • 4. Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.
    Kuriyan AE; Albini TA; Townsend JH; Rodriguez M; Pandya HK; Leonard RE; Parrott MB; Rosenfeld PJ; Flynn HW; Goldberg JL
    N Engl J Med; 2017 Mar; 376(11):1047-1053. PubMed ID: 28296617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA should stand firm on stem-cell treatments.
    Nature; 2016 Jul; 535(7610):7-8. PubMed ID: 27383946
    [No Abstract]   [Full Text] [Related]  

  • 6. Issue of transparency in stem cell therapy.
    Akhtar J
    J Coll Physicians Surg Pak; 2012 Jun; 22(6):347-8. PubMed ID: 22630090
    [No Abstract]   [Full Text] [Related]  

  • 7. Stem-cell scientists grapple with clinics.
    Ledford H
    Nature; 2011 Jun; 474(7353):550. PubMed ID: 21720336
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA challenges stem-cell clinic.
    Cyranoski D
    Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct-to-consumer stem cell marketing and regulatory responses.
    Sipp D
    Stem Cells Transl Med; 2013 Sep; 2(9):638-40. PubMed ID: 23934911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rejuvenating Regenerative Medicine Regulation.
    Charo RA; Sipp D
    N Engl J Med; 2018 Feb; 378(6):504-505. PubMed ID: 29320637
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter campaign sought to pressure FDA action on stem cell clinics.
    Dolgin E
    Nat Med; 2014 Aug; 20(8):796-7. PubMed ID: 25100513
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA proposes mechanism for disseminating information about off-label uses.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1449-50. PubMed ID: 9676288
    [No Abstract]   [Full Text] [Related]  

  • 13. The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions.
    Turner L
    Perspect Biol Med; 2018; 61(1):7-24. PubMed ID: 29805145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Texas prepares to fight for stem cells.
    Cyranoski D
    Nature; 2011 Sep; 477(7365):377-8. PubMed ID: 22049545
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-based approaches towards treating age-related macular degeneration.
    Baradaran-Rafii A; Sarvari M; Alavi-Moghadam S; Payab M; Goodarzi P; Aghayan HR; Larijani B; Rezaei-Tavirani M; Biglar M; Arjmand B
    Cell Tissue Bank; 2020 Sep; 21(3):339-347. PubMed ID: 32157501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem-cell therapy takes off in Texas.
    Cyranoski D
    Nature; 2012 Feb; 483(7387):13-4. PubMed ID: 22382952
    [No Abstract]   [Full Text] [Related]  

  • 17. Bilateral Retinal Detachments After Intravitreal Injection of Adipose-Derived 'Stem Cells' in a Patient With Exudative Macular Degeneration.
    Saraf SS; Cunningham MA; Kuriyan AE; Read SP; Rosenfeld PJ; Flynn HW; Albini TA
    Ophthalmic Surg Lasers Imaging Retina; 2017 Sep; 48(9):772-775. PubMed ID: 28902341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GATT implementation and generic drug approval.
    Safir PO; Lassman SM
    Food Drug Law J; 1996; 51(2):295-302. PubMed ID: 11820203
    [No Abstract]   [Full Text] [Related]  

  • 19. RIKEN suspends first clinical trial involving induced pluripotent stem cells.
    Garber K
    Nat Biotechnol; 2015 Sep; 33(9):890-1. PubMed ID: 26348942
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA's claims over stem cells upheld.
    Cyranoski D
    Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.